Daito Pharmaceutical Co., Ltd. (TYO:4577)

Japan · Delayed Price · Currency is JPY

1,317.00

-4.00 (-0.30%)

Nov 13, 2026, 3:30 PM JST

Market Cap	37.22B +1.3%
Revenue (ttm)	49.53B -2.8%
Net Income	3.17B +59.4%
EPS	109.05 +66.2%
Shares Out	28.26M
PE Ratio	12.08
Forward PE	13.61
Dividend	45.00 (3.42%)
Ex-Dividend Date	Nov 27, 2026

Volume	50,800
Open	1,313.00
Previous Close	1,321.00
Day's Range	1,308.00 - 1,321.00
52-Week Range	1,120.00 - 1,521.00
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 14, 2027

About Daito Pharmaceutical

Daito Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients (APIs) for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company also engages in wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. Daito Pharmaceutical Co., Ltd. was formerly known as Daito Corporation ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1942

Employees 1,085

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4577

Full Company Profile

Financial Performance

In fiscal year 2026, Daito Pharmaceutical's revenue was 50.65 billion, an increase of 0.01% compared to the previous year's 50.64 billion. Earnings were 3.16 billion, an increase of 65.67%.

Financial Statements